Il naltrexone nel trattamento del prurito

Translated title of the contribution: Naltrexone in the treatment of pruritus

Stefane Veraldi, Fabio Celotti, Ruggrero Caputo

Research output: Contribution to journalArticle

Abstract

Naltrexone is a cyclopropyl derivative of oxymorphone which behaves as a competitive antagonist of opioid receptors. Naltrexone is usually used in weaning opioid-dependent patients. The rationale behind the use of naltrexone in the treatment of chronic, diffuse and therapy-resistant pruritus is based on the fact that the opioids used in the treatment of chronic pain (in particular morphine) often cause a type of pruritus which is resistant to traditional antipruritic drugs, and that using naltrexone prevents this pruritus from appearing. Furthermore, the degranulation of basophils and mastocytes and histamine release which are caused by morphine, are inhibited by naltrexone. Naltrexone has therefore been successfully used in cholestatic and uremie pruritus. The authors present the preliminary results of a clinical study on the use of naltrexone in patients with chronic pruritus due to skin diseases.

Original languageItalian
Pages (from-to)149-154
Number of pages6
JournalTrends in Medicine
Volume6
Issue number2
Publication statusPublished - Apr 2006

Fingerprint

Naltrexone
Pruritus
Morphine
Opioid Analgesics
Therapeutics
Oxymorphone
Antipruritics
Basophils
Histamine Release
Opioid Receptors
Weaning
Skin Diseases

ASJC Scopus subject areas

  • Internal Medicine
  • Pharmacology (medical)

Cite this

Veraldi, S., Celotti, F., & Caputo, R. (2006). Il naltrexone nel trattamento del prurito. Trends in Medicine, 6(2), 149-154.

Il naltrexone nel trattamento del prurito. / Veraldi, Stefane; Celotti, Fabio; Caputo, Ruggrero.

In: Trends in Medicine, Vol. 6, No. 2, 04.2006, p. 149-154.

Research output: Contribution to journalArticle

Veraldi, S, Celotti, F & Caputo, R 2006, 'Il naltrexone nel trattamento del prurito', Trends in Medicine, vol. 6, no. 2, pp. 149-154.
Veraldi S, Celotti F, Caputo R. Il naltrexone nel trattamento del prurito. Trends in Medicine. 2006 Apr;6(2):149-154.
Veraldi, Stefane ; Celotti, Fabio ; Caputo, Ruggrero. / Il naltrexone nel trattamento del prurito. In: Trends in Medicine. 2006 ; Vol. 6, No. 2. pp. 149-154.
@article{d978c3463f4f40128c8c6c0439c3531a,
title = "Il naltrexone nel trattamento del prurito",
abstract = "Naltrexone is a cyclopropyl derivative of oxymorphone which behaves as a competitive antagonist of opioid receptors. Naltrexone is usually used in weaning opioid-dependent patients. The rationale behind the use of naltrexone in the treatment of chronic, diffuse and therapy-resistant pruritus is based on the fact that the opioids used in the treatment of chronic pain (in particular morphine) often cause a type of pruritus which is resistant to traditional antipruritic drugs, and that using naltrexone prevents this pruritus from appearing. Furthermore, the degranulation of basophils and mastocytes and histamine release which are caused by morphine, are inhibited by naltrexone. Naltrexone has therefore been successfully used in cholestatic and uremie pruritus. The authors present the preliminary results of a clinical study on the use of naltrexone in patients with chronic pruritus due to skin diseases.",
keywords = "Naltrexone, Pruritus",
author = "Stefane Veraldi and Fabio Celotti and Ruggrero Caputo",
year = "2006",
month = "4",
language = "Italian",
volume = "6",
pages = "149--154",
journal = "Trends in Medicine",
issn = "1594-2848",
publisher = "Pharma Project Group Edizioni Scientifiche (PPG)",
number = "2",

}

TY - JOUR

T1 - Il naltrexone nel trattamento del prurito

AU - Veraldi, Stefane

AU - Celotti, Fabio

AU - Caputo, Ruggrero

PY - 2006/4

Y1 - 2006/4

N2 - Naltrexone is a cyclopropyl derivative of oxymorphone which behaves as a competitive antagonist of opioid receptors. Naltrexone is usually used in weaning opioid-dependent patients. The rationale behind the use of naltrexone in the treatment of chronic, diffuse and therapy-resistant pruritus is based on the fact that the opioids used in the treatment of chronic pain (in particular morphine) often cause a type of pruritus which is resistant to traditional antipruritic drugs, and that using naltrexone prevents this pruritus from appearing. Furthermore, the degranulation of basophils and mastocytes and histamine release which are caused by morphine, are inhibited by naltrexone. Naltrexone has therefore been successfully used in cholestatic and uremie pruritus. The authors present the preliminary results of a clinical study on the use of naltrexone in patients with chronic pruritus due to skin diseases.

AB - Naltrexone is a cyclopropyl derivative of oxymorphone which behaves as a competitive antagonist of opioid receptors. Naltrexone is usually used in weaning opioid-dependent patients. The rationale behind the use of naltrexone in the treatment of chronic, diffuse and therapy-resistant pruritus is based on the fact that the opioids used in the treatment of chronic pain (in particular morphine) often cause a type of pruritus which is resistant to traditional antipruritic drugs, and that using naltrexone prevents this pruritus from appearing. Furthermore, the degranulation of basophils and mastocytes and histamine release which are caused by morphine, are inhibited by naltrexone. Naltrexone has therefore been successfully used in cholestatic and uremie pruritus. The authors present the preliminary results of a clinical study on the use of naltrexone in patients with chronic pruritus due to skin diseases.

KW - Naltrexone

KW - Pruritus

UR - http://www.scopus.com/inward/record.url?scp=33646530984&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33646530984&partnerID=8YFLogxK

M3 - Articolo

AN - SCOPUS:33646530984

VL - 6

SP - 149

EP - 154

JO - Trends in Medicine

JF - Trends in Medicine

SN - 1594-2848

IS - 2

ER -